We are live on ! Find out more
CVRS

CORINDUS VASCULAR ROBOTICS, INC
CVRS

Delisted

CVRS was delisted on the 28th of October, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in CORINDUS VASCULAR ROBOTICS, INC in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 101 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 101 → 0 (-101)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $543M → $0 (-$543M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 101

Holders
–
Holders Change
-101
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
101
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$85.5M
2
HEC
Hudson Executive Capital
New York
-$60.9M
3
Capital World Investors
Capital World Investors
California
-$46.5M
4
AAM
Alpine Associates Management
Florida
-$39.5M
5
SGCM
Sand Grove Capital Management
United Kingdom
-$30.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
76
Metropolitan Life Insurance Company (MetLife)
New York
– -$151K -35,216 Closed
KC
77
Kellner Capital
New York
– -$116K -27,200 Closed
DC
78
Davenport & Co
Virginia
– -$69K -23,000 Closed
Victory Capital Management
79
Victory Capital Management
Texas
– -$96K -22,331 Closed
VCM
80
Vivaldi Capital Management
Illinois
– -$91K -21,164 Closed
TC
81
Trilogy Capital
California
– -$75K -17,700 Closed
AB
82
Amalgamated Bank
New York
– -$69K -16,074 Closed
Citigroup
83
Citigroup
New York
– -$67K -15,646 Closed
Citadel Advisors
84
Citadel Advisors
Florida
– -$67K -15,631 Closed
Legal & General Group
85
Legal & General Group
United Kingdom
– -$65K -15,303 Closed
Principal Financial Group
86
Principal Financial Group
Iowa
– -$65K -15,102 Closed
PPA
87
Parametric Portfolio Associates
Washington
– -$53K -12,469 Closed
GCP
88
GSA Capital Partners
United Kingdom
– -$52K -12,249 Closed
Stifel Financial
89
Stifel Financial
Missouri
– -$51K -12,000 Closed
BNP Paribas Financial Markets
90
BNP Paribas Financial Markets
France
– -$49.8K -11,635 Closed
ProShare Advisors
91
ProShare Advisors
Maryland
– -$45K -10,461 Closed
MFG
92
Merit Financial Group
Georgia
– -$44K -10,250 Closed
Bank of Montreal
93
Bank of Montreal
Ontario, Canada
– -$37K -8,773 Closed
AIP
94
Ameritas Investment Partners
Nebraska
– -$35K -8,101 Closed
BFEC
95
Benjamin F. Edwards & Company
Missouri
– -$17K -4,000 Closed
WAM
96
Wolverine Asset Management
Illinois
– -$17K -4,000 Closed
Northwestern Mutual Wealth Management
97
Northwestern Mutual Wealth Management
Wisconsin
– -$14K -3,325 Closed
TRCT
98
Tower Research Capital (TRC)
New York
– -$6K -1,439 Closed
LTFS
99
Ladenburg Thalmann Financial Services
Florida
– -$2K -400 Closed
AG
100
Advisor Group
Arizona
– -$1K -200 Closed
1 2 3
4

CVRS Hedge Fund Activity: Q4 2019 in Review

0 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in CORINDUS VASCULAR ROBOTICS, INC (CVRS) for Q4 2019, worth a combined $0 — down 100% from $543M a quarter earlier.

Sellers outnumbered buyers: 101 funds closed out of CVRS and 0 opened new positions — a net loss of 101 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was HealthCor Management, exiting entirely with an estimated $85.5M sold.

  • 0 institutional investors held CORINDUS VASCULAR ROBOTICS, INC (CVRS) as of Q4 2019, down from 101 in Q3 2019.
  • Funds reported $0 of CORINDUS VASCULAR ROBOTICS, INC stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new CORINDUS VASCULAR ROBOTICS, INC positions in Q4 2019 and 101 closed out, a net change of -101 holders.
  • The largest CORINDUS VASCULAR ROBOTICS, INC seller in Q4 2019 was HealthCor Management, an estimated $85.5M sold.

Based on aggregated 13F filings for Q4 2019.